Home / Healthcare/ GSK to shut Bangladesh drug-making factory by 2018

GSK to shut Bangladesh drug-making factory by 2018


Comments / {{hitsCtrl.values.hits}} Views / Tuesday, 31 July 2018 00:00


DHAKA (Reuters): GlaxoSmithKline will shut its drug manufacturing operations in Bangladesh by the end of this year and will continue with its healthcare business, the managing director of its local businesses said on Friday.

Globally, GSK’s pharmaceuticals business has seen sluggish growth in recent years. The company unveiled a new restructuring program to deliver annual cost savings of GBP 400 million by 2021.

Nakibur Rahman said the board of GSK Bangladesh Ltd. last Thursday decided to close the drug-making factory in Bangladesh.

He said GSK Bangladesh would continue with its profitable consumer healthcare business that produces items like Horlicks, Sensodyne and Glaxose-D.

 “All of our medicines are substitutable with generic and therefore, patients should be able to access a range of suitable alternatives,” Nakibur said. He also said the company’s decision would impact about 1,000 employees. GSK Bangladesh will now seek shareholders’ nod for a final decision.

 “GSK will run pharmaceuticals in our emerging markets region as an integrated operation, putting in place the right commercial structure in markets to deliver a sustainable growth ambition,” Nakibur said without elaborating further.

The State-run Investment Corporation of Bangladesh owns 12% stake in the company, while 6% of the shares are held by public and different institutions.


Share This Article


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Automation and machine learning: Helping organisations extract deeper value from data

Tuesday, 22 January 2019

The world is in the midst of a data explosion. Humans are generating an estimated 2.5 quintillion bytes of data every single day1, according to Forbes, and more data was created in the past two years than in all of human history. No wonder data now r


SL tourism: From TOM to experience the brand in 2019

Tuesday, 22 January 2019

Last week I had just crossed the border that separates Laos from Thailand and was on route via land to Thailand. My mind was on Laos – a country branded globally as ‘Simply Beautiful’ (backed by the ADB in 2018) to attract visitors into the cou


Questionable (or absurd) official report on poverty indicators

Tuesday, 22 January 2019

The latest Report issued by the Ministry of National Policies and Economic Affairs on ‘Poverty Indicators’ is both questionable and outrageous.1This Ministry is under the responsibility of the Prime Minister, Ranil Wickremesinghe. Most of the sta


Teaching the younger generation to observe professional ethics is the need of the hour

Tuesday, 22 January 2019

When Sri Lanka got independence in 1948, it was one of the most promising nations both in Asia and in the Commonwealth countries. It had luckily emerged unscathed after the Second World War unlike our neighbours. Sri Lanka furthermore did not have to


Columnists More